Apollo Endosurgery IncのEPS Q / Q
Apollo Endosurgery IncのEPS Q / Qは何ですか。
Apollo Endosurgery IncのEPS Q / Qは136.36%です。
EPS Q / Qの定義は何ですか。
四半期EPS成長率(Quarterly EPS growth rate)は、過去4四半期の業績と比較して過去4四半期のEPSの増加です。
The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
NASDAQのセクタHealth CareにおけるEPS Q / Qの企業と比べるApollo Endosurgery Inc
Apollo Endosurgery Incは何をしますか。
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Apollo Endosurgery Incと類似のeps q / q
- Elevate Credit IncのEPS Q / Qは133.33%です。
- Cedar Realty Trust IncのEPS Q / Qは133.33%です。
- Concho Resources IncのEPS Q / Qは134.43%です。
- Arrowhead PharmaceuticalsのEPS Q / Qは134.48%です。
- Crowdstrike IncのEPS Q / Qは135.29%です。
- Magnolia Oil & Gas CorpのEPS Q / Qは135.71%です。
- Apollo Endosurgery IncのEPS Q / Qは136.36%です。
- OvintivのEPS Q / Qは137.14%です。
- American Hotel Income Properties REIT LPのEPS Q / Qは137.50%です。
- HC2 IncのEPS Q / Qは137.50%です。
- AstraZeneca PlcのEPS Q / Qは137.88%です。
- PDD IncのEPS Q / Qは138.64%です。
- ERYTECH Pharma S.AのEPS Q / Qは139.22%です。